7561/13381US=66 / Câncer
Rogers AB, Houghton JM. Helicobacter-based mouse models of digestive system carcinogenesis. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 267-95. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5.

HELICOBACTER; CARCINOGENESE; NEOPLASIAS DO SISTEMA DIGESTORIO; INFLAMACAO; INFECCOES POR HELICOBACTER; HELICOBARTER PYLORI; HELICOBACTER HEPATICUS; CAMUNDONGOS; MODELOS DE DOENCAS; ANIMAL

7562/13381US=66 / Câncer
Dehn D, Taylor A, Fischer TJ, Malinowski DP, Shroyer KR. Screening for molecular markers of cervical papillomavirus infection: overview of methods and their clinical implications. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 297-310. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5.

MARCADORES MOLECULARES DE INFECCAO PELO PAPILOMA VIRUS CERVICAL; CANCER CERVICAL; HPV; P16; PROE ™C; TOPO &*945;2; MCM2; MCM7

7563/13381US=66 / Câncer
Khan G. Screening for Epstein-Barr Virus in Hodgkin's lymphoma. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 311-22. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5.

TRIAGEM PARA O VIRUS EPSTEIN-BARR NO LINFOMA DE HODGKIN; LINFOMA DE HODGKIN; INFLAMACAO; REED-STERNBERG; EBV; EBER HIBRIDACAO IN SITU

7564/13381US=66 / Câncer
Zhu Q, Weiner AJ. A hepatitis C virus xenograft mouse efficacy model. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 323-31. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5.

VIRUS DA HEPATITE C. XENOENXERTO; VIRUS DA HEPATITE C; MURINO; MODELO DE TUMOR; ANTIVIRAL; REPLICON

7565/13381US=66 / Câncer
Martin CM, Astbury K, McEvoy L, O'Toole S, Sheils O, O'Leary J. Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 333-59. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5.

PERFIL DE EXPRESSAO GENICA EM CANCER DE COLO UTERINO: IDENTIFICACAO DE NOVOS MARCADORES PARA DIAGNOSTICO DA DOENCA E TERAPIA; PAPILOMAVIRUS HUMANO; P16; TOPO2A; MICROARRAY; ANALISE BIOINFORMATICA; TAQMAN PCR

7566/13381US=66 / Câncer
Avissar P, Malinowski DP. Detection and genotyping analysis of human papilloma virus isolates from liquid-based cervical cytology specimens. In: Kozlov SV. Inflammation and cancer: methods and protocols: experimental models and practical approaches. New York: Humana Press, 2009. p. 361-70. (Methods in Molecular Biology n.511 - Springer Protocols) ISBN 978-1-934115-14-5.

ANALISE DO VIRUS DO PAPILOMA HUMANO ISOLADOS; AMOSTRAS DE CITOLOGIA CERVICAL; NEOPLASIA CERVICAL; PAPILOMAVIRUS HUMANO; PCR; ANALISE DA SEQUENCIA DE DNA; E6 GENOTIPAGEM

7567/13381US=66 / Biol/Mol
Hiyama K, Hiyana E, Shay JW. Telomeres and telomerase in humans. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 3-21. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

TELOMEROS E TELOMERASE EM HUMANOS; TELOMEROS; TELOMERASE; CELULA GERMINAL; CELULA CANCEROSA; CELULAS-TRONCO; IMORTALIZACAO CELULAR; TELOMERO DISFUNCAO; FIM-REPLICACAO PROBLEMA; STAFE MORTALIDADE; LIMITE DE HAYFLICK; FIM-REPLICACAO PROBLEMA; FASE DE MORTALIDADE; LIMITE DE HAYFLICK; TERT; TERC

7568/13381US=66 / Biol/Mol
Dimitrova N. Telomere-binding proteins in humans. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 23-46. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

TELOMERE PROTEINAS DE LIGACAO EM HUMANOS; SHELTERIN; T-LOOP; CAIXA ELETRONICO; ATR; NHEJ; HR

7569/13381US=66 / Biol/Mol
Drpcrynski AY, Sachs PC, Elmore LW, Holt SE. Regulation of telomere through transcriptional and posttranslational mechanisms. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 47-85. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

TELOMERASE; ENVELHECIMENTO; QUIMIOTERAPICOS; TRANSCRICAO; TELOMERO

7570/13381US=66 / Biol/Mol
Diehl MC, Elmore LW, Holt SE. Telomere dysfunction and the DNA damage response. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 87-125. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

TELOMERE DISFUNCAO E RESPOSTA A DANOS DO DNA; TELOMERO PROTEINAS DE LIGACAO; MANUTENCAO DOS TELOMEROS; DISFUNCAO; DANOS NO DNA; INSTABILIDADE GENOMICA

7571/13381US=66 / Biol/Mol
Pickett HA, Reddel RR. Alternative lengthening of telomeres in human cells. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 127-48. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

ALTERNATIVA ALONGAMENTO DOS TELOMEROS EM CELULAS HUMANAS; TELOMERO; MECANISMO DE MANUTENCAO DOS TELOMEROS; ALTERNATIVA ALONGAMENTO DOS TELOMEROS; RECOMBINACAO HOMOLOGA; ALT-ASSOCIADOS CORPOS PML

7572/13381US=66 / Biol/Mol
Huang X, Ju Z. Mouse model: telomeres and telomerase in stem cell and cancer. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 149-80. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

TELOMEROS E DA TELOMERASE EM CELULAS-TRONCO E CANCER; TELOMERO; CELULAS-TRONCO; CANCER

7573/13381US=66 / Biol/Mol
Hiyama E, Hiyama H. Diagnostic value I: solid tumors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 181-210. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

TUMORES SOLIDOS; TELOMERASE; TRANSCRIPTASE REVERSA HUMANA TELOMERASE; TERT; ASPIRATIVA POR AGULHA FINA; CITOLOGIA; PROTOCOLO DE AMPLIFICACAO TELOMERICA REPETICAO; TRAP; DIAGNOSTICO; PROGNOSTICO; HIBRIDIZACAO IN SITU; ISH; IMUNO-HISTOQUIMICA; IHC

7574/13381US=66 / Biol/Mol
Ohyashiki JH, Ohyashiki K. Diagnostic value II: hematopoietic malignancies. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 211-24. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

DOENCAS MALIGNAS HEMATOPOIETICAS; TELOMEROS; CELULAS ESTAMINAIS HEMATOPOIETICAS; LEUCEMICAS DE CELULAS-TRONCO

7575/13381US=66 / Biol/Mol
Herbert BS, Goldblatt EM. Therapeutic targets and drugs I: telomerase and telomerase inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 225-49. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

ALVOS TERAPEUTICOS E DROGAS I; INIBIDORES DA TELOMERASE; TELOMERASE; HTERT; HTERC; TELOMERASE INIBIDORES DE TELOMERASE DE ATIVIDADE; TELOMEROS; OLIGONUCLEOTIDEOS; TELOMERASE PROTEINAS ASSOCIADAS; CANCER; ENSAIOS CLINICOS

7576/13381US=66 / Biol/Mol
Punchihewa C, Yang D. Therapeutic targets and drugs II: G-quadruplex and G-quadruplex inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 251-80. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

ALVOS TERAPEUTICOS E MEDICAMENTOS II; G-QUADRUPLEX E G-QUADRUPLEX INIBIDORES; TELOMERO HUMANO; G-QUADRUPLEX; META DROGA ANTICANCER; G-QUADRUPLEX LIGANTES; POLIMORFISMO ESTRUTURA TELOMERICA G-QUADRUPLEX

7577/13381US=66 / Biol/Mol
Seimiya H, Tsuruo T. Therapeutic targets and drugs III: tankyrase 1, telomere-binding proteins, and inhibitors. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 281-91. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

ALVOS TERAPEUTICOS E DROGAS III; TELOMERO PROTEINAS DE LIGACAO E INIBIDORES; TANKYRASE 1; TRF1; POLY(ADP-RIBOSIL); SHELTERIN; TRF2; POT1

7578/13381US=66 / Biol/Mol
Fujiwara T, Urata Y, Tanaka N. Therapeutic targets and drugs IV: telomerase-specific gene and vector-based therapies for human cancer. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 293-312. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

ALVOS TERAPEUTICOS E MEDICAMENTOS IV; TERAPIAS TELOMERASE ESPECIFICA DE GENES. BASEADO EM VETOR PARA O CANCER HUMANO; TELOMERASE; HTERT; ADENOVIRUS; GFP; IMAGEM

7579/13381US=66 / Biol/Mol
Hiyama E. Protocol I: telomerase activity and telomerase expression. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 315-35. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

PROTOCOLO I; ATIVIDADE DA TELOMERASE; EXPRESSAO DA TELOMERASE; TRAP; TELOMERASE; TERT; TERC; TECNICAS DE DETECCAO IN SITU

7580/13381US=66 / Biol/Mol
Shimamoto A, Aoki E, Sera AM, Tahara H. Protocol II: importance and methods of telomere G-tail length quantification. In: Hiyama K, editor. Telomeres and telomerase in cancer. New York: Springer, 2009. p. 337-50. (Cancer Drug Discovery and Development) ISBN 978-1-60327-306-0.

PROTOCOLO II; QUANTIFICACAO DOS TELOMEROS DE COMPRIMENTO G-TAIL; COMPRIMENTO TOLOMERE; G-TAIL TELOMERO HPA; TELOMERO - A LIGACAO AS PROTEINAS; DANOS NO DNA; APOPTOSE; PENT; T-OLA; PREMATURA SINDROME DE ENVELHECIMENTO; RELACIONADA COM A IDADE DOENCA

Primeira | Anterior | Próxima | Última